BMAL2

Basic helix-loop-helix ARNT like 2 Q8WYA1 BMAL2_HUMAN
Protein Coding Chr 12 12p11.23 Swiss-Prot reviewed Entrez 56938
Mutations
40
CL 23 · Tissue 0
Samples
29
CL 23 · Tissue 0
Peptides
37
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations40230
Samples29230
Peptides37200

Function

BMAL2 · Basic helix-loop-helix ARNT like 2

This gene encodes a basic helix-loop-helix transcription factor belonging to the PAS (PER, ARNT, SIM) superfamily. The PAS proteins play important roles in adaptation to low atmospheric and cellular oxygen levels, exposure to certain environmental pollutants, and diurnal oscillations in light and temperature. This protein forms a transcriptionally active heterodimer with the circadian CLOCK protein, the structurally related MOP4, and hypoxia-inducible factors, such as HIF1alpha. Consistent with its role as a biologically relevant partner of circadian and hypoxia factors, this protein is coexpressed in regions of the brain such as the thalamus, hypothalamus, and amygdala. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000266503 Q8WYA1 40 37

Gene Properties

Type
Protein Coding
Chromosome
12
Cytoband
12p11.23
Entrez ID
Aliases
ARNTL2CLIFMOP9PASD9bHLHe6

Recurrent Mutations

All 37 amino-acid changes on canonical ENST00000266503 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in BMAL2 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in BMAL2 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Cell Non-Hodgkins Lymphoma
1/26 4%
0/0 0%
T-Lymphoblastic Leukemia
1/40 2%
0/0 0%
Endometrial Carcinoma
5/42 12%
1/612 0%
Melanoma
4/210 2%
1/1899 0%
Esophageal Carcinoma
1/23 4%
0/769 0%
Non-Small Cell Lung Carcinoma
1/304 0%
1/1390 0%
Colorectal Carcinoma
2/143 1%
1/3239 0%
Breast Carcinoma
2/144 1%
1/3264 0%
Other Solid Cancers
1/94 1%
0/1515 0%
Head and Neck Carcinoma
1/85 1%
0/1574 0%
Prostate Carcinoma
1/13 8%
0/2105 0%
Glioma
0/52 0%
1/2127 0%
Gastric Carcinoma
1/74 1%
0/1809 0%
Other Blood Cancers
1/61 2%
0/2725 0%
B-Cell Non-Hodgkins Lymphoma
1/88 1%
0/2534 0%

Mutation Distribution

Where BMAL2 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in BMAL2 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

Mutations

All 40 mutations in BMAL2

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide